Area of research
Epidemiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Diabetes, Cardiovascular Risks, and Lipoproteins, Liver Disease Diagnosis and Treatment, Adipokines, Inflammation, and Metabolic Diseases, and Diet, Metabolism, and Disease.
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)